Larimar Therapeutics Inc (LRMR)

12:06 PM

Bronstein, Gewirtz & Grossman, LLC Encourages Larimar Therapeutics, Inc. (LRMR) Investors to Inquire about Securities Investigation - ACCESS Newswire

12:06 PM

11:28 AM

Visualizing Larimar Therapeutics Inc. stock with heatmapsRate Cut & High Return Trade Opportunity Guides - newser.com

11:28 AM

04:38 AM

Real time breakdown of Larimar Therapeutics Inc. stock performance2025 Top Gainers & Free High Return Stock Watch Alerts - newser.com

04:38 AM

04:23 AM

Is Larimar Therapeutics Inc. stock poised for growthJuly 2025 Earnings & Weekly Top Gainers Trade List - newser.com

04:23 AM

12:24 PM

Larimar Reports Positive Long-Term Data on Nomlabofusp in Friedreich’s Ataxia - MSN

12:24 PM

Oct 16, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Larimar Therapeutics, Inc. (LRMR) And Encourages Investors to Reach Out - ACCESS Newswire

Oct 16, 2025

Oct 16, 2025

Larimar Therapeutics, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsLRMR - MarketScreener

Oct 16, 2025

Oct 16, 2025

LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire

Oct 16, 2025

Oct 15, 2025

LRMR Investors Have Opportunity to Join Larimar Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Benzinga

Oct 15, 2025

Oct 15, 2025

How to track smart money flows in Larimar Therapeutics Inc.Trade Entry Report & Fast Exit and Entry Strategy Plans - newser.com

Oct 15, 2025

Oct 15, 2025

Is Larimar Therapeutics Inc. (ZA71) stock worth buying before Fed actionMarket Trend Review & Free Real-Time Volume Trigger Notifications - newser.com

Oct 15, 2025

Oct 15, 2025

Multi factor analysis applied to Larimar Therapeutics Inc.Long Setup & Weekly Setup with ROI Potential - newser.com

Oct 15, 2025

Oct 14, 2025

Larimar Therapeutics, Inc. Securities Lawsuit Investigation - Claim Depot

Oct 14, 2025

Oct 14, 2025

Larimar Therapeutics Reports Promising Clinical Data Update - TipRanks

Oct 14, 2025

Oct 14, 2025

Larimar Therapeutics, Inc. Updates on Nomlabofusp Development - TradingView

Oct 14, 2025

Oct 14, 2025

What candlestick patterns are forming on Larimar Therapeutics Inc.Earnings Trend Report & Daily Oversold Stock Bounce Ideas - newser.com

Oct 14, 2025

Oct 14, 2025

How Larimar Therapeutics Inc. (ZA71) stock compares with top peersMarket Activity Recap & Precise Entry and Exit Recommendations - newser.com

Oct 14, 2025

Oct 13, 2025

Market reaction to Larimar Therapeutics Inc.’s recent newsMarket Performance Report & Free Safe Entry Trade Signal Reports - newser.com

Oct 13, 2025

Oct 13, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc.LRMR - PR Newswire

Oct 13, 2025

Oct 10, 2025

Larimar Therapeutics (NASDAQ:LRMR) Given Sell (D-) Rating at Weiss Ratings - MarketBeat

Oct 10, 2025

Oct 10, 2025

Intraday pattern recognizer results for Larimar Therapeutics Inc.2025 Buyback Activity & Consistent Profit Focused Trading Strategies - newser.com

Oct 10, 2025

Oct 10, 2025

How to forecast Larimar Therapeutics Inc. trends using time seriesQuarterly Profit Review & Stock Portfolio Risk Control - newser.com

Oct 10, 2025

Oct 10, 2025

Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

Oct 10, 2025

Oct 09, 2025

Lost Money on Larimar Therapeutics, Inc. (LRMR)? Possible FraudContact Levi & Korsinsky Today - Newsfile

Oct 09, 2025

Oct 09, 2025

Volatility clustering patterns for Larimar Therapeutics Inc.July 2025 PostEarnings & Free Real-Time Volume Trigger Notifications - newser.com

Oct 09, 2025

Oct 09, 2025

What MACD and RSI say about Larimar Therapeutics Inc.Trade Ideas & Verified Stock Trade Ideas - newser.com

Oct 09, 2025

Oct 09, 2025

Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 09, 2025

Oct 07, 2025

Larimar announces 25 mg, 50 mg data from OL study of nomlabofusp - MSN

Oct 07, 2025

Oct 06, 2025

Citizens JMP Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $18 - 富途牛牛

Oct 06, 2025

Oct 06, 2025

Why Larimar Therapeutics Inc. (ZA71) stock fits value portfoliosDip Buying & Short-Term Trading Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

Using Python tools to backtest Larimar Therapeutics Inc. strategiesJuly 2025 Pullbacks & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 06, 2025

Oct 06, 2025

Can you recover from losses in Larimar Therapeutics Inc.2025 Price Momentum & Risk Controlled Stock Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

What’s next for Larimar Therapeutics Inc. stock priceEarnings Overview Report & Accurate Technical Buy Alerts - newser.com

Oct 05, 2025

Oct 04, 2025

What analysts say about Larimar Therapeutics Inc stockDouble Top/Bottom Patterns & Low Risk Trading Portfolio - earlytimes.in

Oct 04, 2025

Oct 04, 2025

Will Positive Nomlabofusp Study Results Alter Larimar Therapeutics' (LRMR) Standing in Rare Disease Treatment? - Yahoo Finance

Oct 04, 2025

Oct 03, 2025

Why Larimar Therapeutics (LRMR) Is Up After Positive Long-Term Results for Friedreich's Ataxia Therapy - Sahm

Oct 03, 2025

Oct 03, 2025

Larimar Therapeutics (NASDAQ:LRMR) Price Target Cut to $21.00 by Analysts at Oppenheimer - Defense World

Oct 03, 2025

Oct 03, 2025

Why ETFs are accumulating Larimar Therapeutics Inc. (ZA71) stockDividend Hike & Real-Time Stock Movement Alerts - newser.com

Oct 03, 2025

Oct 02, 2025

Oppenheimer Maintains Larimar Therapeutics (LRMR) Outperform Recommendation - Nasdaq

Oct 02, 2025